Lexeo Therapeutics (LXEO) Earnings Date & Reports

Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

LXEO is expected to report earnings to rise 14.10% to -88 cents per share on May 08

Lexeo Therapeutics LXEO Stock Earnings Reports

Q1'25

Est.

$-0.89

Q4'24

Missed

by $0.06

Q3'24

Missed

by $0.17

Q2'24

Beat

by $0.13

Q1'24

Missed

by $0.02

The last earnings report on March 24 showed earnings per share of -77 cents, missing the estimate of -72 cents. With 608.28K shares outstanding, the current market capitalization sits at 89.96M.

View a ticker or compare two or three

Compare

LXEO